Home
/
The Digest
/
mBIOTA Labs Partners with LyfeMD to Improve SIBO & IMO Care for Canadian Patients
mBIOTA Labs Partners with LyfeMD to Improve SIBO & IMO Care for Canadian Patients
The partnership improves knowledge of SIBO and IMO, accessibility of mBIOTA Elemental Diet with nutritional support across Canada.
Santa Monica, Calif., March 3, 2026 – mBIOTA Labs, an emerging medical food company revolutionizing medical nutrition for the management of gastrointestinal (GI) conditions, today announced a strategic partnership with LyfeMD, a virtual clinic providing evidence-based lifestyle programs for people living with gastrointestinal conditions in Canada. The partnership increases patient access in Canada to mBIOTA Elemental Diet, a clinically proven and trusted GI management solution, and nutritional support after the protocol via LyfeMD’s team of dietitian specialists.
mBIOTA Labs will work closely with LyfeMD providers to expand clinical knowledge and recommendations of palatable elemental diets and Low Fermentation Eating based on the latest research findings. The collaboration emphasizes a growing global recognition of small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) and the progress made to provide patients with better management options. Ultimately, this partnership will drive better outcomes for patients by providing longer-term care support and remission maintenance through diet.
“Our team identified a need to offer patients an elemental formula that was both clinically appropriate and easy for them to consume,” said Lorian Taylor, RD, PhD, CEO of LyfeMD. “mBIOTA Elemental Diet fills this gap and more. mBIOTA has invested meaningful time in educating our dietitian team on the safe and effective use of mBIOTA Elemental Diet, as well as the Low Fermentation Eating diet to support sustained relief for patients, which will not only equip our team with more care options but empower our patients to feel better sooner and longer.”
“LyfeMD and mBIOTA Labs have a shared mission of advancing patient care with solutions that have demonstrated efficacy and are backed by published evidence,” said Nicola Wodlinger, CEO of mBIOTA Labs. “mBIOTA Labs is committed to improving the quality of life of patients living with debilitating gastrointestinal symptoms and working closely with GI dieticians at LyfeMD will enable patients in Canada to receive the support they need.“
LyfeMD creates care plan recommendations tailored to each patient’s condition, goals, and daily life. It offers nutritional guidance, mental wellness, health coaching and patient education to its network of thousands of patients with gastrointestinal and related immune-mediated disorders whom it supports. Led by Dr. Lorian Taylor, PhD, RD, Dr. Maitreyi Raman, MD, FRCPC, and Dr. Puneeta Tandon, MD, FRCPC, leading Canadian experts in nutrition and behavior change for chronic disease, LyfeMD equips patients with lifestyle therapies developed specifically for digestive diseases from evidence-based research as part of Alberta’s Collaboration of Excellence for Nutrition in Digestive Disease (Ascend), a program with experts from the University of Calgary and University of Alberta.
To learn more about mBIOTA Labs and mBIOTA Elemental Diet, visit www.mBIOTA.com. mBIOTA Labs’ customers can schedule a free consultation with LyfeMD here.
About mBIOTA Labs
mBIOTA Labs empowers individuals with evidence-based nutrition solutions that enhance quality of life. Trusted by the medical community, mBIOTA Labs harnesses proprietary Amino Taste Modification Technology (ATMT) to create science-backed medical foods designed to support individuals with a wide range of digestive issues. mBIOTA's award-winning, clinically proven, palatable elemental diet, mBIOTA Elemental™, revolutionizes medical nutrition for the dietary management of GI dysfunction, including small intestinal bacterial overgrowth (SIBO), intestinal methanogen overgrowth (IMO), irritable bowel syndrome (IBS), inflammatory bowel diseases (IBD) such as Crohn’s disease and colitis, eosinophilic esophagitis (EoE), and other conditions. mBIOTA is actively investigating and researching expanded applications of the elemental diet to aid and provide solutions to more patients. Learn more about mBIOTA Labs and published research supporting mBIOTA Elemental Diet by visiting www.mBIOTA.com.
Contacts
For mBIOTA Labs:
Matter Communications
mbiota@matternow.com
Share
